BNP Paribas Asset Management
SILK

BNP Paribas Asset Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

BNP Paribas Asset Management’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-323,821
Closed -$4.85M – 869
2023
Q3 		$4.85M Sell
323,821
-297,073
-48% -$6.18M 0.01% 524
2023
Q2 		$20.2M Sell
620,894
-52,354
-8% -$1.91M 0.06% 288
2023
Q1 		$26.3M Buy
673,248
+95,516
+17% +$4.67M 0.09% 238
2022
Q4 		$30.5M Buy
577,732
+17,169
+3% +$836K 0.11% 217
2022
Q3 		$25.2M Sell
560,563
-7,087
-1% -$305K 0.1% 236
2022
Q2 		$20.7M Buy
567,650
+57,145
+11% +$2.08M 0.08% 280
2022
Q1 		$21.1M Buy
510,505
+34,634
+7% +$1.22M 0.07% 292
2021
Q4 		$20.3M Buy
475,871
+8,672
+2% +$434K 0.07% 318
2021
Q3 		$25.7M Buy
467,199
+53,372
+13% +$2.79M 0.1% 245
2021
Q2 		$19.8M Buy
+413,827
New +$21.1M 0.07% 317

Other funds holding SILK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BNP Paribas Asset Management's SILK Position: Q4 2023 in Review

BNP Paribas Asset Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2023, closing a stake of 323,821 shares — an estimated $4.85M sold.

BNP Paribas Asset Management first reported a position in SILK in Q2 2021 and held it in 10 quarters. The position peaked at $30.5M in Q4 2022. 133 funds tracked by Wall St. Rank hold SILK as of Q4 2023.

  • BNP Paribas Asset Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • BNP Paribas Asset Management sold 323,821 Silk Road Medical, Inc. Common Stock shares in Q4 2023, an estimated $4.85M.
  • BNP Paribas Asset Management first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2021 and held it in 10 quarters.
  • BNP Paribas Asset Management's Silk Road Medical, Inc. Common Stock position peaked at $30.5M in Q4 2022.
  • 133 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2023.

Based on BNP Paribas Asset Management's 13F filing for Q4 2023, filed 9 Feb 2024.